Immunochemistry Analyzer boosts laboratory productivity.
Press Release Summary:
Designed for labs that typically perform less than 200 immunoassay tests per day, ARCHITECT® i1000SR® provides continuous access to reagents and samples while it is running. Unit can accommodate 65 patient samples and process up to 100 tests/hr. It is able to prioritize emergency test results and turn them around in less than 16 min. To facilitate training of new laboratory personnel, instrument features wide test menu and minimal maintenance needs.
Original Press Release:
Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
Highly Anticipated ARCHITECT(R) i1000SR(R) Analyzer Enhances Workflow and Boosts Laboratory Productivity
ABBOTT PARK, Ill., April 15 /-- Abbott (NYSE:ABT) has introduced the ARCHITECT(R) i1000SR(R) immunochemistry analyzer, expanding its ARCHITECT family of diagnostics instrument systems for clinical laboratories. Designed for labs that typically perform less than 200 immunoassay tests per day, the instrument addresses many of the workflow challenges common in today's laboratories.
With the increased demand for diagnostic testing, laboratories, both large and small, need to process tests as quickly and efficiently as possible. By providing continuous access to reagents and samples while the instrument is running, the ARCHITECT i1000SR enhances laboratory productivity. Additionally, a wide test menu, user-friendly software and low maintenance make it easy to train new laboratory personnel on the instrument's operation.
"Because time and ease of use are so critical in the testing environment, Abbott worked extensively with customers very early in the development phase and designed an instrument that could help smaller labs overcome the same productivity obstacles faced by larger labs," said Cass Grandone, divisional vice president, Systems Development, Abbott Diagnostics. "The ARCHITECT i1000SR analyzer is ideal for facilities running less than 200 tests per day and offers productivity benefits, such as highly efficient sample processing, usually reserved for larger testing facilities. Since ARCHITECT utilizes common reagents, consumables and software user interfaces, larger laboratories may be interested in using the instrument as a back-up system to the i2000SR."
The ARCHITECT i1000SR analyzer can process up to 100 tests per hour. The instrument accommodates 65 patient samples and has the capability to prioritize emergency test results and turn them around in less than 16 minutes.
Similar to ARCHITECT ci8200(TM) and ci16200(TM), the analyzer is part of the ARCHITECT family, with important features including:
-- True Family Commonality. Key components, including reagents, can be shared across ARCHITECT instruments and multiple testing sites for effective and efficient patient care.
-- Enhanced Assay and System Dynamics. ARCHITECT instruments offer advanced technology, which means laboratories, physicians and, ultimately, patients can be confident in the accuracy of test results.
-- Integration without Compromise. The ARCHITECT family combines immunoassay and clinical chemistry technologies without jeopardizing key performance, including turnaround time or accuracy of results.
Abbott recently introduced three other instruments in the ARCHITECT family: the ARCHITECT c16000(TM) clinical chemistry analyzer, the ARCHITECT ci16200, an integrated immunoassay and clinical chemistry analyzer, and the ARCHITECT i4000SR(TM) analyzer for high volume immunoassay testing.
About Abbott Diagnostics
Abbott Diagnostics is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, blood banks, physician offices and clinics. With more than 69,000 institutional customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, cost effectiveness and flexibility. Abbott has helped transform the practice of medical diagnostics from an art to a science through the company's commitment to improving patient care and lowering overall costs. The history of Abbott Diagnostics is filled with examples of first-of-a-kind products and significant technological advancements.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at www.abbott.com/.
